These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 13713025)

  • 61. Consensus Conference on Anti-D Prophylaxis. Edinburgh, United Kingdom, 8-9 April 1997. Papers and abstracts.
    Br J Obstet Gynaecol; 1998 Nov; 105 Suppl 18():iv, 1-44. PubMed ID: 10328662
    [No Abstract]   [Full Text] [Related]  

  • 62. [Evaluation of the Center for Rh-negative Mothers. Hospital Paula Jaraquemada (3 years)].
    Krug A; Bianchi R; Pérez N; Ilabaca G; Farías S; Rojas E
    Rev Chil Obstet Ginecol; 1981; 46(4):206-14. PubMed ID: 6099901
    [No Abstract]   [Full Text] [Related]  

  • 63. A second case of hemolytic disease of the newborn due to anti-Jsa.
    Levene C; Rudolphson Y; Shechter Y
    Transfusion; 1980; 20(6):714-5. PubMed ID: 7192023
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Haemolytic disease of the newborn.
    Whitfield CR; Lee D
    BMJ; 1990 Mar; 300(6727):814. PubMed ID: 2157515
    [No Abstract]   [Full Text] [Related]  

  • 65. Haemolytic disease of the newborn due to antibodies other than rhesus anti-D.
    Br Med J (Clin Res Ed); 1981 Aug; 283(6290):514-5. PubMed ID: 6790046
    [No Abstract]   [Full Text] [Related]  

  • 66. The use of Rh immune globulin: a review.
    Sutton GP; Jay A; Lim YS; Noland JE; Boral LI
    Indiana Med; 1988 Apr; 81(4):321-2. PubMed ID: 2834434
    [No Abstract]   [Full Text] [Related]  

  • 67. The detection of anti-D in Rho (D)-negative infants born of Rho (D)-positive mothers.
    Bowen FW; Renfield M
    Pediatr Res; 1976 Apr; 10(4):213-5. PubMed ID: 818607
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Maternal-fetal hemorrhage: its incidence and sensitizing effects.
    Jennings ER; Clauss B
    Am J Obstet Gynecol; 1978 Aug; 131(7):725-7. PubMed ID: 99038
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Rho(D) immune globulin. When to use it in the Rho(D)-negative woman.
    Lavery JP
    Postgrad Med; 1984 Mar; 75(4):259-64. PubMed ID: 6322145
    [No Abstract]   [Full Text] [Related]  

  • 70. Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newborn.
    Brinc D; Lazarus AH
    Hematology Am Soc Hematol Educ Program; 2009; ():185-91. PubMed ID: 20008198
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Blocked D phenomenon and relevance of maternal serologic testing.
    Jain A; Kumawat V; Marwaha N
    Immunohematology; 2015; 31(3):116-8. PubMed ID: 26829177
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Hemolytic disease of the neonate secondary to anti-Fya.
    Weinstein L; Taylor ES
    Am J Obstet Gynecol; 1975 Mar; 121(5):643-5. PubMed ID: 1115167
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Features of hemolytic disease in a newborn from rare Rh isoimmunization to E antigen (Rh) in a mother possessing the genes CDe (Rh1)].
    SANSONE G
    Minerva Pediatr; 1949 Dec; 1(12):429-34. PubMed ID: 15404631
    [No Abstract]   [Full Text] [Related]  

  • 74. Rare Diego blood group phenotype Di(a+b-), I. Anti-Dib causing hemolytic disease of the newborn.
    Ishimori T; Fukumoto Y; Abe K; Nakajima H; Nakamura H
    Vox Sang; 1976; 31(1):61-3. PubMed ID: 945642
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Consensus conference on anti-D prophylaxis, April 7 & 8, 1997: final consensus statement. Royal College of Physicians of Edinburgh/Royal College of Obstetricians and Gynaecologists.
    Urbaniak SJ
    Transfusion; 1998 Jan; 38(1):97-9. PubMed ID: 9482402
    [No Abstract]   [Full Text] [Related]  

  • 76. Hemolytic disease of the newborn caused by a high titer anti-group B IgG from a group A mother.
    Wang M; Hays T; Ambruso DR; Silliman CC; Dickey WC
    Pediatr Blood Cancer; 2005 Nov; 45(6):861-2. PubMed ID: 16007582
    [No Abstract]   [Full Text] [Related]  

  • 77. [Anti-M antibodies in the pathogenesis of hemolytic disease of the newborn].
    Lenkiewicz B; Kuśnierz-Alejska G; Lukowska J; Klimaszewska A
    Acta Haematol Pol; 1989; 20(2):229-34. PubMed ID: 2638542
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Haemolytic disease of the newborn due to Rhesus anti-e antibody.
    Chapman J; Waters AH
    Vox Sang; 1981; 41(1):45-7. PubMed ID: 6798758
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Antigen specificity determines anti-red blood cell IgG-Fc alloantibody glycosylation and thereby severity of haemolytic disease of the fetus and newborn.
    Sonneveld ME; Koelewijn J; de Haas M; Admiraal J; Plomp R; Koeleman CA; Hipgrave Ederveen AL; Ligthart P; Wuhrer M; van der Schoot CE; Vidarsson G
    Br J Haematol; 2017 Feb; 176(4):651-660. PubMed ID: 27891581
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Experimental erythroblastosis fetalis in rabbits. II. The passage of blood group antigens and their specific isoantibodies across the placenta.
    KELLNER A; HEDAL EF
    J Exp Med; 1953 Jan; 97(1):51-60. PubMed ID: 13022861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.